✦ LIBER ✦

2100 ORAL Prediction of brain relapse (BR) in HER-2 positive metastatic breast cancer (MBC) patients (pts)

✍ Scribed by R. Duchnowska; B. Czartoryska-Arlukowicz; B. Radecka; B. Szostakiewicz; K. Sosinska; A. Karpinska; R. Dziadziuszko; E. Staroslawska; T. Kubiatowski; C. Sczylik

Book ID: 118625704
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 57 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(07)70862-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brain metastases in HER-2 positive metas

Brain metastases in HER-2 positive metastatic breast cancer (MBC) patients

✍ R. Duchnowska; Czartoryska-Arlukowicz; B. Radecka; B. Szostakiewicz; A. Karpinsk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Prediction of brain relapse by gene expr

Prediction of brain relapse by gene expression analysis in HER2-positive metastatic breast cancer patients

✍ R. Duchnowska; J. Jassem; C. Szczylik; G.W. Sledge Jr.; L. Li; B. Czartoryska-Ar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Risk factors for brain relapse in HER2-p

Risk factors for brain relapse in HER2-positive metastatic breast cancer patients

✍ Renata Duchnowska; Rafał Dziadziuszko; Bogumiła Czartoryska-Arłukowicz; Barbara 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 219 KB

5000 ORAL Long-term Outcome of HER2-posi

5000 ORAL Long-term Outcome of HER2-positive (HER2+) Metastatic Breast Cancer (MBC) Patients (pts) Achieving Durable Complete Remission (DCR) After Trastuzumab (T)-containing Chemotherapy (CT)

✍ Gullo, G.; Zuradelli, M.; Kelleher, F.; Sclafani, F.; Donovan, N. O'; Lyons, T.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

412 POSTER High incidence of brain metas

412 POSTER High incidence of brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (pts) treated with trastuzumab and chemotherapy

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 280 KB

2009 POSTER Safety of the combination of

2009 POSTER Safety of the combination of lapatinib (L) plus trastuzumab (T) in patients (pts) with HER2-Positive (+) metastatic breast cancer (MBC)

✍ A. Storniolo; M. Koehler; A. Preston; E. Rappold; J. Byrne; S. Stein; M. Ewer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB